RT Journal Article
SR Electronic
T1 Ageing and Dementia: Age-Period-Cohort Effects of Policy Intervention in England, 2006-2016
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.13.21253508
DO 10.1101/2021.03.13.21253508
A1 Kamila Kolpashnikova
YR 2021
UL http://medrxiv.org/content/early/2021/03/13/2021.03.13.21253508.abstract
AB Background Dementia is one of the most important challenges of our time. According to the Dementia Statistics Hub, only about 66% of all UK residents with dementia were diagnosed in 2017-2018. Yet, there are reservations about the early diagnosis of dementia-related diseases. As a result, the UK National Screening Committee does not recommend systematic population screening of dementia.Methods This study added additional evidence of the effectiveness of the National Dementia Strategy and increased numbers of diagnosis of dementia on the younger cohorts of the elderly, using the intrinsic estimator age-period-cohort models and the English Longitudinal Study of Ageing data.Results Age effects show that screening and diagnosis increases in volume only among those aged 75 and above, suggesting that many of the younger elderly were not diagnosed. Period effects show that although there was an initial increase due to new policy implementation, the trend stalled in later years, indicating that the increase might not have been even across the period when controlled for age and cohort. The study also shows that cohort effects indicate lower prevalence in younger cohorts controlled for age and period.Conclusions Although more research in diverse contexts is warranted, this study cautions against the abandonment of timely diagnosis and increased screening and shows some effectiveness of prevention strategies on the national level.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study is supported by the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant (892101).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable--secondary data analysisAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesELSA data is accessible through UKDS